The Resound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, priced at $4,764. In HearAdvisor's lab testing, it earned a SoundScore of 3.87 out of 5, resulting in a B grade. This places it in the middle of the pack among prescription hearing aids, ranking 21st out of 34 devices tested in its category.
The Nexia demonstrates clear strengths in specific areas. Speech understanding in quiet environments measured notably above average, and own-voice comfort scored well above the category mean—suggesting users may experience less of the hollow or boomy sensation that can occur with hearing aids. Feedback handling was excellent, achieving a perfect 5.0 score in both fit conditions.
However, the Nexia showed significant weakness in noisy environments, scoring 1.12 points below the category average for speech in noise—a critical metric for real-world hearing situations like restaurants or social gatherings. Music streaming quality also fell below average, which may disappoint users who frequently stream audio from their smartphones.
At this premium price point, the competitive landscape presents challenges for the Nexia. Several devices in the same price range—including the Oticon Intent (4.70) and Phonak Sphere Infinio (4.64)—delivered substantially higher overall scores in our testing. For budget-conscious consumers, options like the Lucid Tala offer comparable or better sound performance at significantly lower cost. The Nexia may suit users who prioritize quiet-environment listening and own-voice comfort over noisy-situation performance, but those facing challenging acoustic environments regularly should consider alternatives.
